Medicamen Biotech Ltd. Live Share Price Today, Share Analysis and Chart

Name: Medicamen Biotech Ltd.: Is Infosys Ltd. worth buying?
Item: Medicamen Biotech Ltd.
Rating: 2.035458375
Author: Trendlyne DVM scores

Slowing Down Stock

about

Medicamen Biotech is engaged in manufacturing of Finished Dosage Forms (FDF).

344.30 -5.80 (-1.66%)

New 52W Low today

14,483

NSE+BSE Volume

NSE 28 Aug, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Medium Financial Strength

50.0 / 100

Mid Valuation

34.2 / 100

Technically Bearish

28.7 / 100

Slowing Down Stock These stocks score good in Quality and also have medium range financials. However, a bad technical scoring and bearish aspects decrease the investor's interest over time. View Similar Embed DVM

No estimates available

Medicamen Biotech Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Medicamen Biotech Ltd. worth buying?

39 Votes:

Buy 76.92%

Sell 17.95%

Hold 5.13%

Medicamen Biotech Ltd. Live Share Price Today, Share Analysis and Chart

Medicamen Biotech is engaged in manufacturing of Finished Dosage Forms (FDF).

New 52W Low today

SWOT Analysis

Medicamen Biotech Live Price Chart